Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.822983
Title: The generation of an innovation climate typology for pharmaceutical IS stakeholders : a case study
Author: Meighu, Michael
ISNI:       0000 0005 0289 4586
Awarding Body: University of Manchester
Current Institution: University of Manchester
Date of Award: 2018
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
This study is a qualitative exploration on the innovation climate within an IS department of a Top 5 Global drug company to develop a comprehensive creative climate taxonomy. 35 innovation stakeholders were interviewed spanning a cross section of the IS function providing a rich view of creative enablers and impediments with the aim of leveraging technology to develop and deliver better medicines. Semi-structured interviews adopting the dramaturgical model were used. An extensive review of the literature was performed which produced an a priori innovation climate typology as the theoretical framework, which was then applied to a case study dataset. The output is an empirical testing of the extant innovation climate typology. A good fit was found. In addition, the contributions from this case study data expands the theoretical framework to produce a more focused niche typology with thick descriptions as support. The 13-level literature classification taxonomy was tested and enlarged to 172 sub classifications providing richer understandings and two mechanisms for climate enablement were recommended. The output of this thesis can be used by innovation managers in Pharma IS Organizations, as they try to leverage innovation to meet the demands of their challenging business environment. The enhanced typology presents a soft a priori template mechanism in which practitioners can view and articulate climates (in Pharma IS departments), which has been identified as a key driver for innovative output. Organizational creativity is not a naturally occurring dynamic, as individuals are inhibited by many human instincts such as personality conflicts, herding of knowledge, competition, and personality profiles. Both enablers and inhibitors are explored.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (D.B.A.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.822983  DOI: Not available
Keywords: organizational creativity ; organizational behavior ; organizational innovation ; knowledge creation ; pharmaceutical innovation ; drug innovation ; biotechnology innovation ; knowledge management ; Information Systems ; creative typology ; creative taxonomy ; IS innovation ; pharmaceuticals ; pharma ; creative climates ; innovation
Share: